Literature DB >> 22694179

Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance.

Annabelle Reaux-Le Goazigo1, Cyril Rivat, Patrick Kitabgi, Michel Pohl, Stéphane Melik Parsadaniantz.   

Abstract

Initial studies implicated the chemokine CXC motif ligand 12 (CXCL12) and its cognate CXC motif receptor 4 (CXCR4) in pain modulation. However, there has been no description of the distribution, transport and axonal sorting of CXCL12 and CXCR4 in rat nociceptive structures, and their direct participation in nociception modulation has not been demonstrated. Here, we report that acute intrathecal administration of CXCL12 induced mechanical hypersensitivity in naive rats. This effect was prevented by a CXCR4-neutralizing antibody. To determine the morphological basis of this behavioural response, we used light and electron microscopic immunohistochemistry to map CXCL12- and CXCR4-immunoreactive elements in dorsal root ganglia, lumbar spinal cord, sciatic nerve and skin. Light microscopy analysis revealed CXCL12 and CXCR4 immunoreactivity in calcitonin gene related peptide-containing peptidergic primary sensory neurons, which were both conveyed to central and peripheral sensory nerve terminals. Electron microscopy clearly demonstrated CXCL12 and CXCR4 immunoreactivity in primary sensory nerve terminals in the dorsal horn; both were sorted into small clear vesicles and large dense-core vesicles. This suggests that CXCL12 and CXCR4 are trafficked from nerve cell bodies to the dorsal horn. Double immunogold labelling for CXCL12 and calcitonin gene related peptide revealed partial vesicular colocalization in axonal terminals. We report, for the first time, that CXCR4 receptors are mainly located on the neuronal plasma membrane, where they are present at pre-synaptic and post-synaptic sites of central terminals. Receptor inactivation experiments, behavioural studies and morphological analyses provide strong evidence that the CXCL12/CXCR4 system is involved in modulation of nociceptive signalling.
© 2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22694179     DOI: 10.1111/j.1460-9568.2012.08179.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  33 in total

Review 1.  Opioid-induced central immune signaling: implications for opioid analgesia.

Authors:  Peter M Grace; Steven F Maier; Linda R Watkins
Journal:  Headache       Date:  2015-03-31       Impact factor: 5.887

2.  HIV-1 Glycoprotein 120 Enhancement of N-Methyl-D-Aspartate NMDA Receptor-Mediated Excitatory Postsynaptic Currents: Implications for HIV-1-Associated Neural Injury.

Authors:  Yan Zhou; Jianuo Liu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2016-12-22       Impact factor: 4.147

3.  Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells.

Authors:  Ihsan Ekin Demir; Kristina Kujundzic; Paulo L Pfitzinger; Ömer Cemil Saricaoglu; Steffen Teller; Timo Kehl; Carmen Mota Reyes; Linda S Ertl; Zhenhua Miao; Thomas J Schall; Elke Tieftrunk; Bernhard Haller; Kalliope Nina Diakopoulos; Magdalena U Kurkowski; Marina Lesina; Achim Krüger; Hana Algül; Helmut Friess; Güralp O Ceyhan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-16       Impact factor: 11.205

4.  Connexin 43 Mediates CXCL12 Production from Spinal Dorsal Horn to Maintain Bone Cancer Pain in Rats.

Authors:  Li-Hua Hang; Shu-Na Li; Hong Luo; Wei-Wei Shu; Zu-Min Mao; Yuan-Feng Chen; Lei-Lei Shi; Dong-Hua Shao
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

5.  Upregulation of Chemokine CXCL12 in the Dorsal Root Ganglia and Spinal Cord Contributes to the Development and Maintenance of Neuropathic Pain Following Spared Nerve Injury in Rats.

Authors:  Liying Bai; Xinru Wang; Zhisong Li; Cunlong Kong; Yonghui Zhao; Jun-Liang Qian; Quancheng Kan; Wei Zhang; Ji-Tian Xu
Journal:  Neurosci Bull       Date:  2016-01-19       Impact factor: 5.203

6.  CXCR4/CX43 Regulate Diabetic Neuropathic Pain via Intercellular Interactions between Activated Neurons and Dysfunctional Astrocytes during Late Phase of Diabetes in Rats and the Effects of Antioxidant N-Acetyl-L-Cysteine.

Authors:  Dan Zhu; Tingting Fan; Yaohua Chen; Xingyue Huo; Yuping Li; Danyong Liu; Yin Cai; Chi Wai Cheung; Jing Tang; Jian Cui; Zhengyuan Xia
Journal:  Oxid Med Cell Longev       Date:  2022-06-28       Impact factor: 7.310

7.  The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.

Authors:  Claudio Antonio da Silva Junior; Célio José de Castro Junior; Elizete Maria Rita Pereira; Nancy Scardua Binda; Juliana Figueira da Silva; Marta do Nascimento Cordeiro; Danuza Montijo Diniz; Flavia Santa Cecilia; Juliano Ferreira; Marcus Vinicius Gomez
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

8.  CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.

Authors:  Silvia Di Prisco; Guendalina Olivero; Elisa Merega; Tommaso Bonfiglio; Mario Marchi; Anna Pittaluga
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-05       Impact factor: 4.147

9.  Stromal Cell-Derived Factor 1 Increases Tetrodotoxin-Resistant Sodium Currents Nav1.8 and Nav1.9 in Rat Dorsal Root Ganglion Neurons via Different Mechanisms.

Authors:  Fang Qiu; Yang Li; Qiang Fu; Yong-Yan Fan; Chao Zhu; Yan-Hong Liu; Wei-Dong Mi
Journal:  Neurochem Res       Date:  2016-04-02       Impact factor: 3.996

10.  CXCR4/CXCL12-mediated entrapment of axons at the injury site compromises optic nerve regeneration.

Authors:  Alexander M Hilla; Annemarie Baehr; Marco Leibinger; Anastasia Andreadaki; Dietmar Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.